North America Tumour Ablation Market – Industry Trends and Forecast to 2029

Market Analysis and Insights : North America Tumour Ablation Market

Data Bridge Market Research analyses that the tumour ablation market growing at a CAGR of 10.50% in the forecast period of 2022 to 2029.

Tumour ablation is a minimally invasive procedure for treating liver, kidney, bone, and lung cancers. Thermal energy is used to heat or cool tissue to cytotoxic levels (less than 40°C or more than 60°C) during tumour ablation. Another approach, which is allegedly non thermal and targets the permeability of the cell membrane, is being developed. There are various modalities utilised worldwide for tumour ablation, including radiofrequency, microwave, laser, high-intensity focused ultrasound, cryoablation, and irreversible electroporation. Although they all serve the same function, each technique has its own set of advantages and disadvantages.

The tumour ablation market is expected to develop due to an increase in the number of cancer patients and technological advancements in tumour ablation equipment based on cost effectiveness, mobility, and accuracy. The rising prevalence of cancer and the high need for safer therapeutic choices are two main factors driving market growth. Other major drivers driving market growth include increased awareness of tumour ablation procedures and the expansion of medical centres over the forecast period.

Rising innovations and adoption of advanced technologies for surgical methods and devices will further provide beneficial opportunities for the market growth.

However, the main factors impeding market growth are shorter equipment lifespans and longer acceptance times for new product releases. Other important obstacles that limit market growth include liver infection, chest cavity or abdominal haemorrhage, abdominal pain, and adverse effects associated with tumour ablation treatment.

This tumour ablation  market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on tumour ablation market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

North America Tumour Ablation Market Scope and Market Size

North America tumour ablation market is segmented on the basis of technology, treatment, and application. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

• Based on technology, the North America tumour ablation market is segmented into radiofrequency (RF) ablation, microwave ablation, cryoablation and other technologies. 
• Based on treatment, the North America tumour ablation market is segmented into percutaneous ablation, laparoscopic ablation and surgical ablation. 
• Based on application, the North America tumour ablation market is segmented into liver cancer, lung cancer, kidney cancer, bone metastasis and others. 

Tumour Ablation Market Country Level Analysis

The Tumour Ablation market is analysed and market size insights and trends are provided by country, technology, treatment, and application as referenced above.

The countries covered in the tumour ablation market report are U.S., Canada and Mexico

U.S. in North America dominates the tumour ablation market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period. This is due to the high healthcare expenditure and rising use of technological advance devices in hospitals.

The country section of the Tumour Ablation market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure growth Installed base and New Technology Penetration

The tumour ablation market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for tumour ablation market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the tumour ablation market. The data is available for historic period 2010 to 2020.

Competitive Landscape and Tumour Ablation Market Share Analysis

The tumour ablation market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to tumour ablation market.

Some of the major players operating in the tumour ablation market are Medtronic, Johnson and Johnson, Services Inc., Ethicon, Inc., Boston Scientific Corporation, Misonix, Inc., EDAP TMS S.A., Theraclion SA, AngioDynamics, Inc., Mermaid Medical A/S, H and SonaCare Medical, LLC among others.

SKU-1784